CNSP - Balance Sheet - CNS Pharmaceuticals, Inc.

Current Liabilities	2.52 M
Accounts Payable	0
Short-Term Debt	326 K
Other Current Liabilities	2.2 M
Non-Current Liabilities	0
Long-Term Debt	0
Other Non-Current Liabilities	0

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018	Dec-2017
ASSETS
Cash & Cash Equivalents	6.5	0.5	10.1	5.0	14.0	7.2	0.3	0.1
Short Term Investments	0	0	0	0	0	0	0	0
Receivables	0.9	0	0	0	0	0	0	0
Inventory	0	0	0	0	0	0	0	0
Other Current Assets	1.3	1.0	5.0	2.5	1.5	0.7	0.3	51.7 K
Total Current Assets	8.7	1.6	12.6	7.5	15.5	7.9	0.6	0.2
PP&E	6 K	4.93 K	5.66 K	16.1 K	23.4 K	18.2 K	0	0
Intangible Assets	0	0	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0	0	0
Long Term Investments	0	0	0	0	0	0	0	0
Other Long Term Assets	36.4 K	0.1	0.5	1.3	0.3	0	95.2 K	0
Other Assets	0	0	0	0	0	0	0	0
Total Assets	8.7	1.7	13.1	8.8	15.9	7.9	0.7	0.2
LIABILITIES
Accounts Payable	0	5.8	3.7	2.0	0.9	0.3	0.1	57.5 K
Short Term Debt	0.3	0.3	0.4	0.4	0.4	0	0.3	0.1
Other Current Liabilities	2.2	0	0.8	0.2	0.5	21.5 K	0.8	41.4 K
Total Current Liabilities	2.5	6.1	4.9	2.1	1.9	0.3	1.2	0.2
Long Term Debt	0	0	0	0	0	0	0	0
Deferred Tax Income	0	0	0	0	0	0	0	0
Other Liabilities	0	0	0	0	0	0	0	0
Total Liabilities	2.5	6.1	4.9	2.1	1.9	0.3	1.2	0.2
EQUITY
Common Stock	1.41 K	6.21 K	1.62 K	27.9 K	23.9 K	16.4 K	12.7 K	10.3 K
Retained Earnings	(84.4)	(69.6)	(50.7)	(35.0)	(20.9)	(11.5)	(7.6)	(0.2)
Other Accumulative Comprehensive Income/Loss	0	0	0	0	0	0	0	0
Total Equity	6.2	(4.4)	8.1	6.6	13.9	7.6	(0.5)	58.5 K
Total Liabilities and Equity	8.7	1.7	13.1	8.8	15.9	7.9	0.7	0.2
SHARES OUTSTANDING
Common Shares Outstanding	38.2	75 K	27.2	17.0	11.0	11.0	11.0	11.0

Free